Xarelto

Type: Product
Name: Xarelto
First reported 9 hours ago - Updated 7 hours ago - 1 reports

FDA Approves New DVT Treatment

Font SizeAAA By Shelley WoodMedscape Medical News Reviewed by Aug. 21, 2014 -- The FDA has approved the use of the anti-clotting drug apixaban (Eliquis) to treat (DVT) and pulmonary embolism (PE).Apixaban is also now approved to lower the risk of DVT ... [Published WebMD - 9 hours ago]
First reported Aug 21 2014 - Updated 14 hours ago - 4 reports

Pfizer, BMS pad bright Q2 with new FDA nod for Eliquis

Pfizer ($PFE) and Bristol-Myers Squibb's ($BMS) Eliquis has been lagging since launch time, trailing behind predecessors Pradaxa and Xarelto. But lately, the drugmakers' efforts have been paying off when it comes to market share, and a new indication ... [Published FiercePharma - 14 hours ago]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports

Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) filings that allege the blood thinner caused patients to suffer uncontrollable internal bleeding and other serious injuries continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According ... [Published Bio-Medicine - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

MHRA launches online oral anticoagulation module

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new online learning module to educate healthcare professionals about new oral anticoagulant drugs.The MHRA hopes the module will help professionals manage the risks and ensure ... [Published PMLive - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Novel oral anticoagulant prescriptions soar, but at a high cost

(Ref: Science Daily)Tags:Study data published in The American Journal of Medicine indicate that novel oral anticoagulants (NOACs) account for 62 percent of all anticoagulant prescriptions but 98 percent of total spending on these therapies, Science Daily ... [Published FirstWord Pharma - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 2 reports

Pradaxa MDL Court Orders Establishment of Qualified Settlement Fund, Notes Rottenstein Law Group LLP

The Rottenstein Law Group, a national personal injury law firm that represents persons who believe they were injured by anticoagulants such as Pradaxa (http://www.rotlaw.com/pradaxa-lawsuit/) and Xarelto (http://www.rotlaw.com/xarelto/), has learned that ... [Published Bio-Medicine - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

3 Reasons Johnson & Johnson Stock Could Rise

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) might be a $280-plus billion dollar company, but it's certainly not growing like one as evidenced by the company's robust growth reported in the second quarter.For the quarter, Johnson & Johnson ... [Published Motley Fool Discussion Boards - Aug 18 2014]
First reported Aug 17 2014 - Updated Aug 17 2014 - 2 reports

Xarelto Lawsuit News: Bernstein Liebhard LLP Notes Publication of New Study Finding Xarelto Brain Bleeding Difficult to Reverse

As Xarelto lawsuits http://www.xareltolawsuitcenter.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study which suggests that brain bleeds associated with the use of the blood thinner are difficult to reverse. ... [Published Bio-Medicine - Aug 17 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 2 reports

New Xarelto Lawsuit Alleges Manufacturers of Blood Thinner Made Misleading Claims to Promote Medication, Bernstein Liebhard LLP Reports

The Firm is evaluating Xarelto lawsuits on behalf of individuals who allegedly suffered intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death due ... [Published Presskontakt.se - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 2 reports

Potential Lawsuit: Xarelto (Rivaroxaban) Lawsuit

Home Page >> Potential Lawsuit >> Xarelto LawsuitA Xarelto lawsuit has been filed against Bayer AG and Janssen, makers of the drug, alleging Xarelto side effects include an increased risk of bleeding events. The plaintiff in the Xarelto side ... [Published Lawyers & Settlements - Aug 13 2014]
First reported Aug 09 2014 - Updated Aug 09 2014 - 3 reports

Xarelto Lawsuit Page Launched By Wright & Schulte LLC In Response to Growing Litigation involving the Blood Thinner

Wright & Schulte LLC has launched a new involving the blood thinner. According to a Reuters report published June 14, 2014, Bayer AG and Janssen Pharmaceuticals are named as that have been filed in the U.S. Though Reuters did not report the details of ... [Published Bio-Medicine - Aug 09 2014]
First reported Jul 30 2014 - Updated Jul 31 2014 - 3 reports

Possible Lawsuit: Bayer Facing Lawsuits over Xarelto Bleeding Events

Home Page >> Potential Lawsuit >> Bayer Facing Lawsuits over Xarelto Bleeding EventsLos Angeles, CA: Bayer AG and Janssen, the makers of Xarelto (Rivaroxaban) EI, are facing a wrongful death lawsuit recently filed by the family of a man ... [Published Lawyers & Settlements - Jul 31 2014]
Entities: Xarelto, Bayer AG, Lawsuit

Quotes

"Once a VTE has occurred, approximately 33% of patients are at risk of a recurrence within 10 years," Pfizer SVP Steve Romano said in a statement. "The Bristol-Myers Squibb and Pfizer alliance is committed to delivering important treatment options to patients and physicians."
If the anticoagulants are discontinued, "normal anticoagulation returns in a relatively short time, particularly when compared with warfarin." He does urge
"The person who is 50, who has a busy professional life with a lot of travel, can't necessarily control their diet, and actually likes to eat things"
"These findings point to the need to conduct ongoing surveillance of the adoption of new agents into clinical practice, as well as the need for robust, real-world comparative-effectiveness analyses of these medications, to enable patients and providers to make informed decisions about their relative benefit, safety, and cost-effectiveness" Choudhry said

More Content

All (193) | News (166) | Reports (0) | Blogs (24) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
FDA Approves New DVT Treatment [Published WebMD - 9 hours ago]
Five things for pharma marketers to know: Frida... [Published Medical Marketing And Media - 13 hours ago]
Pfizer, BMS pad bright Q2 with new FDA nod for ... [Published FiercePharma - 14 hours ago]
Rapid Uptake of New Oral Anticoagulants in AF P... [Published Diabetes Care - 16 hours ago]
FDA Grants Label Expansion For Bristol-Myers An... [Published Bidness Etc - 18 hours ago]
FDA approves BMS/Pfizer’s Eliquis in DVT and PE [Published PMLive - 19 hours ago]
Pfizer/BMS blood thinner gains new licence [Published Pharmafocus - 21 hours ago]
FDA Grants New Indication For Pfizer, Bristol-M... [Published Forbes.com - Aug 21 2014]
Getting the Dabigatran (Pradaxa) Story [Published Theheart.org - Aug 21 2014]
FDA approves use of Eliquis to treat leg, lung ... [Published Yahoo! Finance - Aug 21 2014]
Xarelto Lawsuits Mount With New Filing in New Y... [Published Bio-Medicine - Aug 21 2014]
Xarelto Lawsuits Mount With New Filing in New Y... [Published PRWeb - Aug 21 2014]
FDA Approves Apixaban (Eliquis) for DVT/PE Trea... [Published Diabetes Care - Aug 21 2014]
MHRA launches online oral anticoagulation module [Published PMLive - Aug 21 2014]
Novel oral anticoagulant prescriptions soar, bu... [Published FirstWord Pharma - Aug 21 2014]
Sell Side Views On Johnson and Johnson [Published Bidness Etc - Aug 20 2014]
Novel Oral Anticoagulant Prescriptions Soar, Bu... [Published theCSRfeed - Aug 20 2014]
Novel oral anticoagulant prescriptions soar, bu... [Published Bio-Medicine - Aug 19 2014]
Novel oral anticoagulant prescriptions soar, bu... [Published EurekAlert! - Aug 19 2014]
Pradaxa MDL Court Orders Establishment of Quali... [Published Bio-Medicine - Aug 19 2014]
Pradaxa MDL Court Orders Establishment of Quali... [Published PRWeb - Aug 19 2014]
3 Reasons Johnson & Johnson Stock Could Rise [Published Motley Fool Discussion Boards - Aug 18 2014]
Take heart, stain alternatives on the way [Published 6minutes.net.au - Aug 18 2014]
Xarelto Lawsuit News: Bernstein Liebhard LLP No... [Published Bio-Medicine - Aug 17 2014]
Xarelto Lawsuit News: Bernstein Liebhard LLP No... [Published Digital Journal - Aug 17 2014]
LARIAT device helps prevent stroke in patients ... [Published Kentucky.com - Aug 16 2014]
New Xarelto Lawsuit Alleges Manufacturers of Bl... [Published Presskontakt.se - Aug 13 2014]
New Xarelto Lawsuit Alleges Manufacturers of Bl... [Published PRWeb - Aug 13 2014]
BMS, Pfizer pull out all the stops to give Eliq... [Published FiercePharma - Aug 13 2014]
British Regulator Launches "Learning Module" on... [Published Stock Nod - Aug 13 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novel Oral Anticoagulant Prescriptions Soar, Bu... [Published theCSRfeed - Aug 20 2014]
Novel anticoagulants accounted for 62% of new prescriptions and 98% of anticoagulant-related healthcare dollars between 2010 and 2013, reports The American Journal of Medicine SOURCE: Elsevier DESCRIPTION: Philadelphia, PA, August 20, 2014 /3BL Media/ ...
Physicians in Brazil and Mexico Ideally Prefer ... [Published PR Newswire: General Business - Jul 23 2014]
BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision Resources Group finds that novel oral anticoagulants (NOACs) such as Xarelto, Boehringer Ingelheim's Pradaxa and Bristol-Myers Squibb/Pfizer's Eliquis are preferred treatments for venous thromboembolism ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 11 2014]
Bayer faces law suits in United States over Xar... [Published Yahoo! Health News - Jun 14 2014]
Germany's Bayer AG faces its first law suits in the United States over anti-clotting drug Xarelto, one of its top five medicines, the Frankfurter Allgemeine Zeitung newspaper reported on Saturday, citing company sources. A Bayer spokesman dec... ...
Top stories in health and medicine, June 10, 2014 [Published KevinMD.com - Jun 10 2014]
From  MedPage Today : AMA Mulls Gun Violence CME . As the AMA’s House of Delegates was meeting in a downtown hotel here, 29 local residents were shot and four killed within a 10-mile radius. Most Breast Ca Patients Fall Short on Exercise . Two-thirds ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Keller Rohrback L.L.P. Investigates Allegations... [Published GlobeNewswire: Acquisitions News - Jul 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.